Development of the loratadine gel for enhanced transdermal delivery

References

• Vlase L, Imre S, Muntean D, Leucuta SE. (2007). Determination of loratadine and its active metabolite in human plasma by highperformance liquid chromatography with mass spectrometry etection. J Pharm Biomed Anal, 44:652–7.
   PubMed Web of Science ®Google Scholar
• Eugene WM. (1997). Loratadine in the treatment of urticaria. Clin Therap, 19:232–42.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Choi HK. (1998). Enhancement of percutaneous absorption of ketoprofen: Effect of vehicles and adhesive matrix. Int J Pharm, 169:95–104.
   Web of Science ®Google Scholar
• Choi JS, Shin SC. (2007). Preparation and evaluation of pranoprofen gel for percutaneous administration. Drug Dev Ind Pharm, 33:19–26.
   PubMed Web of Science ®Google Scholar
• Langer R. (2004). Transdermal drug delivery: Past progress, current status, and future prospects. Adv Drug Deliv Rev, 56:557–8.
   PubMed Web of Science ®Google Scholar
• Cho CW, Kim SJ, Yang KH, Song JH, Jeong HJ, Shin SC. (2008). Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer. Drug Deliv, 15:423–8.
   PubMed Web of Science ®Google Scholar
• Durrhein H, Flynn GL, Higuchi WI, Behl CR. (1980). Permeation of hairless mouse skin. I: Experimental methods and comparison with human epidermis permeation by alkanols. J Pharm Sci, 69:781.
   PubMed Web of Science ®Google Scholar
• Chien YW, Lambert HJ. (1975). Solubilization of steroids by multiple co-solvent systems. Chem Pharm Bull, 23:1085.
   Web of Science ®Google Scholar
• Chien YW, Lau EPK. (1976). Controlled drug release from polymeric delivery devices. IV: In vitro-in vivo correlation of subcutaneous release of norgestomet from hydrophilic implants. J Pharm Sci, 65:488.
   PubMed Web of Science ®Google Scholar
• Banerjee P, Ritschal W. (1989). Transdermal permeation of vasopressin. II. Influence of Azone on in vitro and in vivo permeation. Int J Pharm, 49:199–204.
   Web of Science ®Google Scholar
• Kim C, Kim J, Chi S, Shim C. (1993). Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int J Pharm, 99:109–18.
   Web of Science ®Google Scholar
• Fuhrman LC, Michniak BB, Behl CR, Malick AW. (1997). Effect of novel penetration enhancers on the transdermal delivery of hydrocortisone: An in vitro species comparison. J Control Release, 45:199–206.
   Web of Science ®Google Scholar
• Mura P, Faucci MT, Bramanti G, Corti P. (2000). Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci, 9:365–72.
   PubMed Web of Science ®Google Scholar
• Carelli V, Di Colo G, Nanoripieri E, Serafini M. (1993). Bile acids as enhancers of steroid penetration through excised hairless mouse skin. Int J Pharm, 89:81–9.
   Web of Science ®Google Scholar
• Magnusson BM, Runn P. (1999). Effect of penetration enhancers on the permeation of the thyrotropin releasing hormone analogue pGlu-3-methyl-His-Pro amide through human epidermis. Int J Pharm, 178:149–59.
   PubMed Web of Science ®Google Scholar
• Tanojo H, Bouwstra JA, Junginger HE, Bodde HE. (1997). In vitro human skin barrier modulation by fatty acid: Skin permeation and thermal analysis studies. Pharm Res, 14:42–9.
   PubMed Web of Science ®Google Scholar
• Oh SY, Jeong SY, Park TG, Lee JH. (1998). Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. J Control Release, 51:161–8.
   PubMed Web of Science ®Google Scholar
• Golden GM, Mckie JE, Potts RO. (1987). Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci, 76:25–8.
   PubMed Web of Science ®Google Scholar
• Elyan BM, Sidhom MB, Plakogiannis FM. (1996). Evaluation of the different fatty acids on the percutaneous absorption of metaproterenol sulphate. J Pharm Sci, 85:101–5.
   PubMed Web of Science ®Google Scholar
• Bhatia KS, Singh J. (1998). Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. J Pharm Sci, 87:462–9.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Yamaoka Y, Jukushima S, Miyawaki K, Taguchi K, Yasuka H, (1998). Skin penetration enhancing action of cis-unsaturated fatty acids with ω-9 and ω-12 chain lengths. Biol Pharm Bull, 21:462–9.
   Google Scholar
• Taguchi K, Fukushima S, Yamaoka Y, Takeuchi Y, Suzuki M. (1999). Enhancement of propylene glycol distribution in the skin by high purity cis-unsaturated fatty acids with different alkyl chain lengths having different double bond position. Biol Pharm Bull, 22:407–11.
   PubMed Web of Science ®Google Scholar
• Cooper ER. (1984). Increased skin permeability for lipophilic molecules. J Pharm Sci, 73:1153–6.
   PubMed Web of Science ®Google Scholar
• Barry BW, Bennett SL. (1987). Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human-skin. J Pharm Pharmacol, 39:535–46.
   PubMed Web of Science ®Google Scholar
• Cappel MJ, Kreuter J. (1991). Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates. Int J Pharm, 69:143–53.
   Web of Science ®Google Scholar
• Iwasa A, Irimoto K, Kasai S, Okuyama H, Nagai T. (1991). Effect of nonionic surfactants on percutaneous absorption of diclofenac sodium. Yakuzaigaaku, 51:16–21.
   Google Scholar
• Lopez A, Llinares F, Cortell C, Herraez M. (2000). Comparative enhancer effects of span 20 with Tween 20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm, 202:133–40.
   PubMed Web of Science ®Google Scholar
• Shin SC, Cho CW, Oh IJ. (2001). Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int J Pham, 222:199–203.
   PubMed Web of Science ®Google Scholar
• Shokri J, Nokhodchi A, Kashbolaghi A, Hassan-Zadeh K, Ghafourian T, Barzegar-Jalali M. (2001). The effect of surfactants on the skin penetration of diazepam. Int J Pharm, 228:99–107.
   PubMed Web of Science ®Google Scholar
• Chowan ZT, Pritchard R. (1978). Effect of surfactants on percutaneous absorption of naproxen. I: Comparisons of rabbit, rat and human excised skin. J Pharm Sci, 67:122–7.
   Google Scholar
• Aungst BJ, Rogers NJ, Shefter E. (1986). Enhancement of naloxon penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm, 33:225–34.
   Web of Science ®Google Scholar
• Gao Z, Crowley WR, Shukla AJ, Johnson JR, Reger JF. (1995). Controlled release of contraceptive steroids from biodegradable and injectable gel formulations; In vivo evaluation. Pharm Res, 12:864–8.
   PubMed Web of Science ®Google Scholar
• Squillante E, Needham T, Maniar A, Kislaliglu S, Zia H. (1998). Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin. Eur J Pharm Biopharm, 46:265–71.
   PubMed Web of Science ®Google Scholar
• Adrian CW, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–18.
   PubMed Web of Science ®Google Scholar